Maze Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 20.0M | 0 | 0 | 0 | 0 | 0 | 2.5M | 165.0M |
| Cost of Goods Sold | 444K | 499K | 0 | 649K | 0 | 0 | 0 | 0 |
| Gross Profit | 19.6M | -499K | 0 | -649K | 0 | 0 | 2.5M | 165.0M |
| R&D Expenses | 33.7M | 27.6M | 25.2M | 28.1M | 27.6M | 22.2M | 19.9M | 19.5M |
| Operating Expenses | 46.1M | 37.6M | 33.0M | 35.8M | 35.4M | 29.7M | 26.7M | 25.4M |
| Operating Income | -26.6M | -38.1M | -33.0M | -36.5M | -35.4M | -29.7M | -24.2M | 139.6M |
| Other Income / Gains | 2.3M | 3.5M | 2.9M | 2.8M | 2.6M | -128K | -802K | 1.2M |
| Net Income | -24.2M | -34.6M | -30.1M | -33.7M | -32.8M | -29.6M | -24.8M | 139.1M |
| EPS (Diluted) | -0.45 | -0.87 | -0.66 | -0.77 | -0.749 | -0.112 | -0.055 | 0.98 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.978 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 |
| General And Administrative Expenses | 12.4M | 10.5M | 7.8M | 8.4M | 7.8M | 7.5M | 6.9M | 5.9M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 12.4M | 10.5M | 7.8M | 8.4M | 7.8M | 7.5M | 6.9M | 5.9M |
| Other Expenses | 0 | -499K | 0 | -649K | 0 | 0 | 0 | 0 |
| Cost And Expenses | 46.6M | 38.1M | 33.0M | 36.5M | 35.4M | 29.7M | 26.7M | 25.4M |
| Interest Income | 3.2M | 3.5M | 2.9M | 2.8M | 2.6M | 1.5M | 1.8M | 1.0M |
| Interest Expense | 866K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 444K | 499K | 571K | 649K | 684K | 705K | 788K | 854K |
| Ebitda | -22.9M | -34.1M | -29.5M | -33.0M | -32.1M | -29.1M | -24.2M | 141.6M |
| Ebitdaratio | -1.145 | 0 | 0 | 0 | 0 | 0 | -9.697 | 0.858 |
| Operating Income Ratio | -1.328 | 0 | 0 | 0 | 0 | 0 | -9.692 | 0.846 |
| Income Before Tax | -24.2M | -34.6M | -30.1M | -33.7M | -32.8M | -29.9M | -25.0M | 140.8M |
| Income Before Tax Ratio | -1.21 | 0 | 0 | 0 | 0 | 0 | -10.012 | 0.853 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | -275K | -279K | 1.7M |
| Net Income Ratio | -1.21 | 0 | 0 | 0 | 0 | 0 | -9.901 | 0.843 |
| Epsdiluted | -0.45 | -0.87 | -0.66 | -0.77 | -0.749 | -0.112 | -0.055 | 0.98 |
| Weighted Average Shs Out | 53.9M | 43.0M | 45.8M | 43.9M | 43.8M | 43.8M | 43.8M | 43.8M |
| Weighted Average Shs Out Dil | 53.9M | 43.0M | 45.8M | 43.9M | 43.8M | 43.8M | 43.8M | 43.8M |